Preferences and Feasibility of Long-Acting Technologies for the Treatment of Hepatitis C Virus: A Survey of Patients in Diverse Low- and Middle-Income Countries.
Furl R, Scarsi KK, Sayles H, Anderson M, Ofimboudem JD, Weld ED, Waked I, Gomaa A, Al-Khatib A, Elshobary FM, Desalegn H, Fisseha H, Solomon S, Mehta S, Owen A, Rannard S, Thomas DL, Swindells S. J Viral Hepat. 2024 Nov 15. doi: 10.1111/jvh.14031. Epub ahead of print. PMID: 39545599.

A precision randomized trial to evaluate the impact of tailored hepatitis C treatment adherence support on HCV treatment outcomes among people who inject drugs in India: Design and Baseline Characteristics of the STOP-C Trial.
Mehta SH, Lau BM, Ehrhardt S, McFall A, Gunaratne MP, Baishya J, Kedar A, Srikrishnan AK, Evans J, Loeb T, Pradeep A, Kumar MS, Thomas DL, Lucas GM, Solomon SS. Am J Epidemiol. 2024 Nov 8:kwae430. doi: 10.1093/aje/kwae430. Epub ahead of print. PMID: 39572371.

High hepatitis C virus reinfection in a community-based sample of people who inject drugs in Imphal, India.
Gunaratne MP, Kedar A, McFall AM, Srikrishnan AK, Chingtham S, Amrose P, Baishya JJ, Sinha AK, Mehta SH, Solomon SS. Int J Drug Policy. 2024 Nov 4;134:104635. doi: 10.1016/j.drugpo.2024.104635. Epub ahead of print. PMID: 39500224.

Key Determinants of SARS-CoV-2 Testing Among Symptomatic Individuals During the Second Wave in Uttar Pradesh, India: An Analysis From Two Districts.
Pandey RR, Agarwal M, Wahl B, Garg T, Jain A. Cureus. 2024 Oct 18;16(10):e71784. doi: 10.7759/cureus.71784. PMID: 39553036; PMCID: PMC11569817.

Pathogen genomic surveillance status among lower resource settings in Asia.
Getchell M, Wulandari S, de Alwis R, Agoramurthy S, Khoo YK, Mak TM, Moe L, Stona AC, Pang J, Momin MHFHA, Amir A, Andalucia LR, Azzam G, Chin S, Chookajorn T, Arunkumar G, Hung DT, Ikram A, Jha R, Karlsson EA, Le Thi MQ, Mahasirimongkol S, Malavige GN, Manning JE, Munira SL, Trung NV, Nisar I, Qadri F, Qamar FN, Robinson MT, Saloma CP, Setk S, Shirin T, Tan LV, Dizon TJR, Thayan R, Thu HM, Tissera H, Xangsayarath P, Zaini Z, Lim JCW, Maurer-Stroh S, Smith GJD, Wang LF, Pronyk P; Asia Pathogen Genomics Initiative (Asia PGI) consortium. Nat Microbiol. 2024 Oct;9(10):2738-2747. doi: 10.1038/s41564-024-01809-4. Epub 2024 Sep 24. PMID: 39317773; PMCID: PMC11445059.

Integrating ethics in public health guideline development: a case-study of the NTCA guidelines on respiratory isolation for persons with TB in community settings.
Kates OS, Shah M. J Infect Dis. 2024 Oct 7:jiae478. doi: 10.1093/infdis/jiae478. Epub ahead of print. PMID: 39373254.

Rights-Based Legal Considerations for TB Isolation Practices in Community Settings in the Post-Pandemic Era.
Bonomo EJ, Shah M. J Infect Dis. 2024 Oct 7:jiae479. doi: 10.1093/infdis/jiae479. Epub ahead of print. PMID: 39373235.

Network-based strategies to combat HCV: Examining social and spatial drivers of transmission among PWID in New Delhi.
Clipman SJ, Mehta SH, Mohapatra S, Srikrishnan AK, Zook KJC, Kumar MS, Lucas GM, Latkin CA, Solomon SS. J Viral Hepat. 2024 Sep;31(9):535-543. doi: 10.1111/jvh.13960. Epub 2024 Jun 4. PMID: 38837275.

Persistently high HIV incidence among men who have sex with men and people who inject drugs attending integrated care centres in India: a longitudinal assessment of clinic-based data
McFall AM, Gunaratne MP, Ganapathi L, Srikrishnan AK, Vasudevan CK, Anand S, Celentano DD, Solomon SS, Mehta SH, Lucas GM.. J Int AIDS Soc. 2024 Sep;27(9):e26361. doi: 10.1002/jia2.26361. PMID: 39301675; PMCID: PMC11413497.

Long-term risk of mortality and loss to follow-up in children and adolescents on antiretroviral therapy in Asia.
Nimkar S, Kinikar A, Mave V, Khol V, Du QT, Nguyen L, Ounchanum P, Nguyen DQ, Puthanakit T, Kosalaraks P, Chokephaibulkit K, Sudjaritruk T, Muktiarti D, Kumarasamy N, Yusoff NKN, Mohamed T, Wati D, Alam A, Fong S, Nallusamy R, Suwanlerk T, Sohn A, Kariminia A; TREAT Asia Pediatric HIV Observational Database of IeDEA Asia‐Pacific. HIV Med. 2024 Sep 26. doi: 10.1111/hiv.13718. Epub ahead of print. PMID: 39324422.

Advancing the chemotherapy of tuberculous meningitis: a consensus view.
Wasserman S, Donovan J, Kestelyn E, Watson JA, Aarnoutse RE, Barnacle JR, Boulware DR, Chow FC, Cresswell FV, Davis AG, Dooley KE, Figaji AA, Gibb DM, Huynh J, Imran D, Marais S, Meya DB, Misra UK, Modi M, Raberahona M, Ganiem AR, Rohlwink UK, Ruslami R, Seddon JA, Skolimowska KH, Solomons RS, Stek CJ, Thuong NTT, van Crevel R, Whitaker C, Thwaites GE, Wilkinson RJ. Lancet Infect Dis. 2024 Sep 26:S1473-3099(24)00512-7. doi: 10.1016/S1473-3099(24)00512-7. Epub ahead of print. PMID: 39342951.

Application of center for disease control and prevention standardized antimicrobial administration ratio to an Indian hospital.
Sarma S, Borde K, Robinson M, Rawat N, Khurana P, Singh V, Singh P, Mehta Y. Antimicrob Steward Healthc Epidemiol. 2024 Sep 25;4(1):e149. doi: 10.1017/ash.2024.396. PMID: 39350946; PMCID: PMC11440567.

Hepatitis B Surface Antigen Loss: What Does Integration Have to Do With a Functional Hepatitis B Virus Cure?
Balagopal A, Thio CL. J Infect Dis. 2024 Sep 23;230(3):529-532. doi: 10.1093/infdis/jiae327. PMID: 38912959.

Association of inadequate sleep with mortality among persons who inject drugs. Sleep Health.
Sun J, Hsu HY, Rabinowitz JA, Sosnowski DW, Piggott DA, Mehta SH, Maher BS, Spira AP, Kirk GD. 2024 Sep 14:S2352-7218(24)00167-0. doi: 10.1016/j.sleh.2024.07.008. Epub ahead of print. PMID: 39278806.

Expanding single-venue services to better engage young people who inject drugs: insights from India.
Ganapathi L, Srikrishnan AK, McFall AM, Gunaratne MP, Kumar MS, Lucas GM, Mehta SH, Solomon SS. Harm Reduct J. 2024 Sep 14;21(1):170. doi: 10.1186/s12954-024-01084-w. PMID: 39272091; PMCID: PMC11401385.

Clinical and diagnostic features of central nervous system tuberculosis in Indian children - a descriptive study
Daniel BD, Selladurai E, Balaji S, Venkatesan A, Venkatesan M, Giridharan P, Shanmugam S, Natrajan S, Karunaianantham R, Kandasamy D, Subramani R, Muthuramalingam K, Pramila SK, Hissar S, Dooley KE, Thakur KT.. Ther Adv Infect Dis. 2024 Sep 12;11:20499361241274251. doi: 10.1177/20499361241274251. PMID: 39290458; PMCID: PMC11406600.

Improving access to tuberculosis preventive treatment for children in Ethiopia: designing a home-based contact management intervention for the CHIP-TB trial through formative research
Salazar-Austin N, Bergman AJ, Mulder C, Tudor C, Mulatu F, Conradie G, Chaisson RE, Golub JE, Churchyard G, Bedru A, Kerrigan D. BMC Health Serv Res. 2024 Sep 10;24(1):1043. doi: 10.1186/s12913-024-11451-9. PMID: 39252005.

A machine-learning based model for automated recommendation of individualized treatment of rifampicin-resistant tuberculosis
Verboven L, Callens S, Black J, Maartens G, Dooley KE, Potgieter S, Cartuyvels R; SMARTT team; Laukens K, Warren RM, Van Rie A. PLoS One. 2024 Sep 6;19(9):e0306101. doi: 10.1371/journal.pone.0306101. PMID: 39241084; PMCID: PMC11379382.

Hazardous Alcohol Use and Its Effect on Direct-Acting Antiviral Therapy Initiation among People with Active Injection Drug Use and Current Hepatitis C Infection
Karimi-Sari H, Lucas GM, Zook K, Weir B, Landry M, Sherman SG, Page KR, Falade-Nwulia O.. Viruses. 2024 Sep 5;16(9):1416. doi: 10.3390/v16091416. PMID: 39339891; PMCID: PMC11437464.

Individual Heterogeneity and Trends in Hepatitis C Infection Risk Among People Who Inject Drugs: A Longitudinal Analysis
Grantz KH, Cepeda J, Astemborski J, Kirk GD, Thomas DL, Mehta SH, Wesolowski A. J Viral Hepat. 2024 Sep 5. doi: 10.1111/jvh.13999. Epub ahead of print. PMID: 39234877.

Lipid and glucose profiles in pregnant women with HIV on tenofovir-based antiretroviral therapy
Eke AC, Brummel SS, Aliyu MH, Stranix-Chibanda L, Eleje GU, Ezebialu IU, Korutaro V, Wabwire D, Matubu A, Mbengeranwa T, Chakhtoura N, Chinula L, McCarthy K, Knowles K, Krotje C, Linton MF, Dooley KE, Sax PE, Brown T, Lockman S; IMPAACT 2010/VESTED Study Team.. Clin Infect Dis. 2024 Sep 2:ciae441. doi: 10.1093/cid/ciae441. Epub ahead of print. PMID: 39219495.

Effect of self-efficacy among persons who inject drugs treated with direct-acting antivirals on Hepatitis C treatment initiation, duration, completion, adherence, and cure
Lopes SS, Pericot-Valverde I, Dotherow JE, Lum PJ, Taylor LE, Mehta SH, Tsui JI, Feinberg J, Kim AY, Norton BL, Page K, Murray-Krezan C, Anderson J, Karasz A, Arnsten J, Moschella P, Heo M, Litwin AH; HERO study group Drug Alcohol Depend. 2024 Sep 1;262:111384. doi: 10.1016/j.drugalcdep.2024.111384. Epub 2024 Jul 6. PMID: 38991632.

Association of primary care engagement with initiation and continuation of medication treatment for opioid use disorder among persons with a history of injection drug use.
Sosnowski DW, Feder KA, Genberg BL, Mehta SH, Kirk GD. Drug Alcohol Depend. 2024 Sep 1;262:111383. doi: 10.1016/j.drugalcdep.2024.111383. Epub 2024 Jul 5. PMID: 38986240; PMCID: PMC11329344.

Prevalence of non-communicable diseases among household contacts of people with tuberculosis: A systematic review and individual participant data meta-analysis
Hamada Y, Quartagno M, Malik F, Ntshamane K, Tisler A, Gaikwad S, Acuna-Villaorduna C, Bhavani PK, Alisjahbana B, Ronacher K, Apriani L, Becerra M, Chu AL, Creswell J, Diaz G, Ferro BE, Galea JT, Grandjean L, Grewal HMS, Gupta A, Jones-López EC, Kleynhans L, Lecca L, MacPherson P, Murray M, Marín D, Restrepo BI, Shivakumar SVBY, Shu E, Sivakumaran D, Vo LNQ, Webb EL, Copas A, Abubakar I, Rangaka MX. Trop Med Int Health. 2024 Sep;29(9):768-780. doi: 10.1111/tmi.14038. Epub 2024 Jul 27. PMID: 39073229; PMCID: PMC11368628.

Pharmaceutical cost dynamics for the treatment of rifampicin-resistant tuberculosis in children and adolescents in South Africa, India, and the Philippines.
Wilkinson T, Garcia-Prats AJ, Sachs T, Paradkar M, Suryavanshi N, Kinikar A, Frias MV, Sinanovic E, Hesseling AC, Seddon JA, Palmer M. PLoS One. 2024 Jul 23;19(7):e0305930. doi: 10.1371/journal.pone.0305930. PMID: 39042708; PMCID: PMC11265651.

Undernourished Household Contacts Are at Increased Risk of Tuberculosis (TB) Disease, but not TB Infection-a Multicenter Prospective Cohort Analysis.
Sinha P, Ezhumalai K, Du X, Ponnuraja C, Dauphinais MR, Gupte N, Sarkar S, Gupta A, Gaikwad S, Thangakunam B, Paradkar M, Christopher DJ, Mave V, Viswanathan V, Ellner JJ, Kornfeld H, Horsburgh CR Jr, Padmapriyadarsini C, Gupte A. Clin Infect Dis. 2024 Jul 19;79(1):233-236. doi: 10.1093/cid/ciae149. PMID: 38652286; PMCID: PMC11259213.

Factors associated with unfavourable treatment outcomes among persons with Pulmonary Tuberculosis: a multicentric prospective cohort study from India.
Prakash Babu S, Ezhumalai K, Raghupathy K, Karoly M, Chinnakali P, Gupte N, Paradkar M, Devarajan A, Dhanasekaran M, Thiruvengadam K, Dauphinais MR, Gupte AN, Shivakumar SB, Thangakunam B, Christopher DJ, Viswanathan V, Mave V, Gaikwad S, Kinikar A, Kornfeld H, Horsburgh R, Chandrasekaran P, Hochberg NS, Salgame P, Gupta A, Roy G, Ellner J, Sinha P, Sarkar S. Clin Infect Dis. 2024 Jul 11:ciae367. doi: 10.1093/cid/ciae367. Epub ahead of print. PMID: 38991034.

Hepatitis B Virus in People who Inject Drugs and Men who Have Sex With Men With HIV in India: A Cross-sectional Study.
Loeb TA, Gunaratne MP, Iqbal S, Anderson M, McFall AM, Amrose P, Rodgers MA, Srikrishnan AK, Balagopal A, Lucas GM, Mehta SH, Thomas DL, Cloherty G, Thio CL, Solomon SS. Open Forum Infect Dis. 2024 Jun 29;11(7):ofae350. doi: 10.1093/ofid/ofae350. PMID: 39022392; PMCID: PMC11252851.

HIV self-testing in India: implementation and qualitative evaluation of a web-based programme with virtual counsellor support.
Kaptchuk RP, Thakker J, Bell J, Okram S, Gopinath U, Mehta SH, Reddy AK, Loeb TA, Arumugam V, Tandon S, Parthasarathy MR, Ghosh SC, Singh A, Joshi DS, Kaur S, Solomon SS, McFall AM. J Int AIDS Soc. 2024 Jun;27(6):e26302. doi: 10.1002/jia2.26302. PMID: 38861458; PMCID: PMC11166186.

HIV-1 low-level viraemia predicts virological failure in first-line and second-line ART-experienced individuals in India: A retrospective longitudinal study.
Dinesha TR, Boobalan J, Kumar CV, Manikandan P, Muhila M, Solomon SS, Srikrishnan AK, Murugavel KG. HIV Med. 2024 Jul;25(7):852-861. doi: 10.1111/hiv.13641. Epub 2024 Apr 25. PMID: 38663865.

Association between Covishield vaccine and menstrual disturbance. Findings from a cross-sectional study among participants of Zero TB cohort in India.
Dorjee K, Namdon T, Topgyal S, Gyatso U, Tsundue T, Dolma T, Kumar V, Lhadon D, Yangkyi T, Khachoe T, Dorjee S, Sadoff RC, Peters D, Gupta A, Paster Z, Chaisson RE, Phunkyi D, Sadutshang TD. Vaccine. 2024 Jun 11;42(16):3572-3577. doi: 10.1016/j.vaccine.2024.04.063. Epub 2024 Apr 27. PMID: 38679512.

Drug resistance and epidemiological success of modern Mycobacterium tuberculosis lineages in western India
Dixit A, Ektefaie Y, Kagal A, Freschi L, Karyakarte R, Lokhande R, Groschel M, Tornheim JA, Gupte N, Pradhan NN, Paradkar MS, Deshmukh S, Kadam D, Schito M, Engelthaler DM, Gupta A, Golub J, Mave V, Farhat M. J Infect Dis. 2024 May 31:jiae240. doi: 10.1093/infdis/jiae240. Epub ahead of print. PMID: 38819323.

High prevalence of hepatitis B virus among MSM living with HIV in India
Iqbal HS, Gunaratne MP, Loeb TA, Pradeep A, McFall AM, Srikrishnan AK, Anderson M, Rodgers MA, Celentano DD, Mehta SH, Clohertly GA, Solomon SS. J Viral Hepat. 2024 May 15;31(5):271-274. doi: 10.1111/jvh.13929. Epub 2024 Feb 22. PMID: 38385866.

Voucher incentives to improve viral suppression among HIV-positive people who inject drugs and men who have sex with men in India: a cluster randomised trial
Solomon SS, McFall AM, Srikrishnan AK, Verma V, Anand S, Khan RT, Kushwaha BS, Vasudevan C, Saravanan S, Paneerselvam N, Kumar MS, Das C, Celentano DD, Mehta SH, Lucas GM. Lancet HIV. 2024 May 15;11(5):e309-e320. doi: 10.1016/S2352-3018(24)00005-5. Epub 2024 Apr 4. PMID: 38583461.

Association between Covishield vaccine and menstrual disturbance. Findings from a cross-sectional study among participants of Zero TB cohort in India
Dorjee K, Namdon T, Topgyal S, Gyatso U, Tsundue T, Dolma T, Kumar V, Lhadon D, Yangkyi T, Khachoe T, Dorjee S, Sadoff RC, Peters D, Gupta A, Paster Z, Chaisson RE, Phunkyi D, Sadutshang TD. Vaccine. 2024 Apr 27:S0264-410X(24)00500-0. doi: 10.1016/j.vaccine.2024.04.063. Epub ahead of print. PMID: 38679512.

HIV-1 low-level viraemia predicts virological failure in first-line and second-line ART-experienced individuals in India: A retrospective longitudinal study
Dinesha TR, Boobalan J, Kumar CV, Manikandan P, Muhila M, Solomon SS, Srikrishnan AK, Murugavel KG. HIV Med. 2024 Apr 25. doi: 10.1111/hiv.13641. Epub ahead of print. PMID: 38663865.

Undernourished Household Contacts Are at Increased Risk of Tuberculosis (TB) Disease, but not TB Infection- a Multicenter Prospective Cohort Analysis
Sinha P, Ezhumalai K, Du X, Ponnuraja C, Dauphinais MR, Gupte N, Sarkar S, Gupta A, Gaikwad S, Thangakunam B, Paradkar M, Christopher DJ, Mave V, Viswanathan V, Ellner JJ, Kornfeld H, Horsburgh CR Jr, Padmapriyadarsini C, Gupte A. Clin Infect Dis. 2024 Apr 23:ciae149. doi: 10.1093/cid/ciae149. Epub ahead of print. PMID: 38652286.

Injection network drivers of HIV prevention service utilization among people who inject drugs: results of a community-based sociometric network cohort in New Delhi, India
Prata Menezes NS, Mehta SH, Wesolowski A, Clipman SJ, Srikrishnan AK, Kumar MS, Zook KJC, Lucas GM, Latkin C, Solomon SS. J Int AIDS Soc. 2024 Apr 15;27(4):e26241. doi: 10.1002/jia2.26241. PMID: 38632848; PMCID: PMC11024448.

Clinical outcomes in children living with HIV treated for non-severe tuberculosis in the SHINE Trial
Chabala C, Wobudeya E, van der Zalm MM, Kapasa M, Raichur P, Mboizi R, Palmer M, Kinikar A, Hissar S, Mulenga V, Mave V, Musoke P, Hesseling AC, McIlleron H, Gibb D, Crook A, Turkova A; SHINE trial team. Clin Infect Dis. 2024 Apr 9:ciae193. doi: 10.1093/cid/ciae193. Epub ahead of print. PMID: 38592950.

What is next for BCG revaccination to prevent tuberculosis?
White RG, Fiore-Gartland AJ, Hanekom WA, Vekemans J, Garcia-Basteiro AL, Churchyard G, Rangaka MX, Frick M, Behr MA, Hill PC, Mave V. Lancet Respir Med. 2024 Mar 15;12(3):e7-e8. doi: 10.1016/S2213-2600(24)00009-2. Epub 2024 Jan 22. PMID: 38272048.

Adverse Pregnancy Outcomes Among Women with Human Immunodeficiency Virus Taking Isoniazid Preventive Therapy During the First Trimester
Gupta A, Hughes MD, Cruz JL, Avihingsanon A, Mwelase N, Severe P, Omoz-Oarhe A, Masheto G, Moran L, Benson CA, Chaisson RE, Swindells S. Clin Infect Dis. 2024 Mar 20;78(3):667-673. doi: 10.1093/cid/ciad583. PMID: 37768207; PMCID: PMC10954322.

Correction: Tuberculosis (TB) Aftermath: study protocol for a hybrid type I effectiveness-implementation non-inferiority randomized trial in India comparing two active case finding (ACF) strategies among individuals treated for TB and their household contacts
Cox SR, Kadam A, Atre S, Gupte AN, Sohn H, Gupte N, Sawant T, Mhadeshwar V, Thompson R, Kendall E, Hofmann C, Suryavanshi N, Kerrigan D, Tripathy S, Kakrani A, Barthwal MS, Mave V, Golub JE; TB Aftermath study team. Trials. 2024 Mar 11;25(1):178. doi: 10.1186/s13063-024-07984-3. Erratum for: Trials. 2022 Aug 5;23(1):635. PMID: 38468342; PMCID: PMC10929208.

Systemic inflammation in pregnant women with HIV: relationship with HIV treatment regimen and preterm delivery
Shivakoti R, Giganti MJ, Lederman MM, Ketchum R, Brummel S, Moisi D, Dadabhai S, Moodley D, Violari A, Chinula L, Owor M, Gupta A, Currier JS, Taha TE, Fowler MG; PROMISE study team. AIDS. 2024 Feb 26. doi: 10.1097/QAD.0000000000003877. Epub ahead of print. PMID: 38411599.

Glycated Hemoglobin Trajectories and Their Association With Treatment Outcomes Among Patients With Pulmonary TB in India: A Prospective Cohort Study
Pardeshi G, Mave V, Gaikwad S, Kadam D, Barthwal M, Gupte N, Atre S, Deshmukh S, Golub JE, Gupte A. Chest. 2024 Feb 15;165(2):278-287. doi: 10.1016/j.chest.2023.08.026. Epub 2023 Sep 4. PMID: 37673207; PMCID: PMC10851276.

The source of Drug-Resistant Bloodstream Infection in the Neonatal Intensive Care Unit, an Ongoing Conversation
Robinson ML, Johnson J, Naik S, Kinikar A, Dohe V, Kagal A, Randive B, Kadam A, Karyakarte R, Mave V, Gupta A, Milstone AM, Manabe YC. Clin Infect Dis. 2024 Feb 1:ciae045. doi: 10.1093/cid/ciae045. Epub ahead of print. PMID: 38301661.

The Impact of Preventive Treatment for Multidrug- and Rifampin-Resistant Tuberculosis Exceeds Trial-Based Estimate
Kasaie P, Pennington J, Gupta A, Dowdy DW, Kendall EA. Clin Infect Dis. 2024 Jan 25;78(1):133-143. doi: 10.1093/cid/ciad557. PMID: 37724763; PMCID: PMC10810707.